首页|益气活血化瘀汤联合达格列净治疗2型糖尿病合并慢性心力衰竭患者的临床疗效

益气活血化瘀汤联合达格列净治疗2型糖尿病合并慢性心力衰竭患者的临床疗效

扫码查看
目的 探讨益气活血化瘀汤联合达格列净治疗2型糖尿病(T2DM)合并慢性心力衰竭(CHF)患者的疗效及其对患者血糖控制、心功能、炎症因子、氧化应激的影响。方法 选取2022年6月至2023年12月新郑市公立人民医院收治的T2DM合并CHF患者116例,采用随机数字表法分为中药联合组、达格列净组,各58例。达格列净组采用达格列净治疗,中药联合组采用益气活血化瘀汤联合达格列净治疗。治疗8周后,比较2组患者临床疗效、血糖控制情况[空腹血糖(FBG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA1c)水平]、心功能指标[心率、左室射血分数(LVEF)、6 min步行距离、N-末端B型利钠肽原(NT-proBNP)]、炎症因子[白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子α(TNF-α)]、氧化应激指标[丙二醛(MDA)、一氧化氮(NO)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)]及不良反应。结果 治疗8周后,中药联合组临床总有效率为96。55%(56/58),高于达格列净组的84。48%(49/58),差异有统计学意义(P<0。05);治疗8周后,中药联合组FBG、2 hPG、HbA1c、心率、血浆NT-proBNP水平低于达格列净组,LVEF、6 min步行距离高于达格列净组,差异均有统计学意义(P<0。05);治疗8周后,中药联合组血清IL-6、hs-CRP、TNF-α、MDA水平低于达格列净组,血清NO、CAT、SOD水平高于达格列净组,差异均有统计学意义(P<0。05);治疗期间,中药联合组不良反应总发生率为6。90%(4/58),低于达格列净组的13。79%(8/58),但差异无统计学意义(P>0。05)。结论 益气活血化瘀汤联合达格列净治疗T2DM合并CHF患者效果显著,可有效调控血糖、改善心功能、缓解氧化应激反应、减轻炎症反应,且用药安全性高。
Clinical efficacy of Yiqi Huoxue Huayu Decoction combined with dapagliflozin in treatment of type 2 diabetes mellitus complicated with chronic heart failure
Objective To investigate the efficacy of Yiqi Huoxue Huayu Decoction combined with dapa-gliflozin in the treatment patients with of type 2 diabetes mellitus(T2DM)complicated with chronic heart fail-ure(CHF)and its effects on blood glucose control,cardiac function,inflammatory factors and oxidative stress.Methods A total of 116 T2DM patients complicated with CHF admitted to Xinzheng Public People's Hospital from June 2022 to December 2023 were selected and divided into the traditional Chinese medicine(TCM)com-bination group and the dapagliflozin group by random number table method,with 58 cases in each group.The dapagliflozin group was treated with dapagliflozin,and the TCM combination group was treated with Yiqi Huoxue Huayu Decoction combined with dapagliflozin.After eight weeks of treatment,the clinical efficacy,blood glucose control[fasting blood glucose(FBG),2 h postmeal blood glucose(2 hPG),glycated hemoglobin(HbA1c)level],cardiac function indexes[heart rate,left ventricular ejection fraction(LVEF),6 min walking distance,N-terminal B-type natriuretic peptide(NT-proBNP)]and inflammatory factors[interleukin-6(IL-6),high-sensitivity C-reactive protein(hs-CRP),tumor necrosis factor-α(TNF-α)],oxidative stress indexes[ma-londialdehyde(MDA),nitric oxide(NO),catalase(CAT),superoxide dismutase(SOD)].Results After 8 weeks of treatment,the total clinical effective rate of TCM combination group was 96.55%(56/58),which was higher than 84.48%(49/58)of the dapagliflozin group,and the difference was statistically significant(P<0.05).After 8 weeks of treatment,the levels of FBG,2 hPG,HbA1c,heart rate and plasma NT-proBNP in the TCM combination group were lower than those in the dapagliflozin group,while LVEF and 6 min walk-ing distance were higher than those in dapagliflozin group,the differences were statistically significant(P<0.05).After 8 weeks of treatment,the serum levels of IL-6,hs-CRP,TNF-α and MDA in the TCM combina-tion group were lower than those in the dapagliflozin group,and the serum levels of NO,CAT and SOD were higher than those in the dapagliflozin group,with statistical significance(P<0.05).During the treatment,the total incidence of adverse reactions in the TCM combination group was 6.90%(4/58),which was slightly low-er than 13.79%(8/58)in the dapagliflozin group,but with no statistical significance(P>0.05).Conclusion Yiqi Huoxue Huayu Decoction combined with dapagliflozin has a significant effect in the treatment of T2DM pa-tients with CHF,which can effectively regulate blood glucose,improve cardiac function,alleviate oxidative stress and reduce inflammation,with high safety.

Yiqi Huoxue Huayu DecoctionDapagliflozinType 2 diabetesChronic heart fail-ureCardiac functionInflammatory factor

荆娇莹、张一心、朱继法、张晓

展开 >

新郑市公立人民医院心血管内科,河南新郑 451100

新郑市公立人民医院中医科,河南郑州 451100

郑州大学第一附属医院心内一科,河南郑州 450000

益气活血化瘀汤 达格列净 2型糖尿病 慢性心力衰竭 心功能 炎症因子

河南省医学科技攻关联合共建项目

LHGJ20201748

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(13)